Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;25(10):2772-2782.
doi: 10.1007/s12094-023-03149-x. Epub 2023 Apr 24.

Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer

Xue Qu #  1 , Yu-Xia Cao #  2 , Yuan-Xin Xing  3 , Qi Liu  4 , Huan-Jie Li  5 , Wei-Hua Yang  2 , Ban-Qin Wang  6 , Shu-Yi Han  7 , Yun-Shan Wang  2
Affiliations
Review

Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer

Xue Qu et al. Clin Transl Oncol. 2023 Oct.

Abstract

The mechanism of deleted in lymphocytic leukemia 2 (DLEU2)-long non-coding RNA in tumors has become a major point of interest in recent research related to the occurrence and development of a variety of tumors. Recent studies have shown that the long non-coding RNA DLEU2 (lncRNA-DLEU2) can cause abnormal gene or protein expression by acting on downstream targets in cancers. At present, most lncRNA-DLEU2 play the role of oncogenes in different tumors, which are mostly associated with tumor characteristics, such as proliferation, migration, invasion, and apoptosis. The data thus far show that because lncRNA-DLEU2 plays an important role in most tumors, targeting abnormal lncRNA-DLEU2 may be an effective treatment strategy for early diagnosis and improving the prognosis of patients. In this review, we integrated lncRNA-DLEU2 expression in tumors, its biological functions, molecular mechanisms, and the utility of DLEU2 as an effective diagnostic and prognostic marker of tumors. This study aimed to provide a potential direction for the diagnosis, prognosis, and treatment of tumors using lncRNA-DLEU2 as a biomarker and therapeutic target.

Keywords: Biomarker; Cancer; Functions; Molecular mechanisms; lncRNA-DLEU2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig.1
Fig.1
Expression of DLEU2 in different tumors
Fig.2
Fig.2
The functional mechanism of DLEU2 in tumors
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Zhou Y, Tian B, Tang J, Wu J, Wang H, Wu Z, et al. SNHG7: A novel vital oncogenic lncRNA in human cancers. Biomed Pharmacother. 2020;124:109921. doi: 10.1016/j.biopha.2020.109921. - DOI - PubMed
    1. Xu W, Wang B, Cai Y, Guo C, Liu K, Yuan C. DLEU2: a meaningful long noncoding RNA in oncogenesis. Curr Pharm Des. 2021;27(20):2337–2343. doi: 10.2174/1381612826666201026150857. - DOI - PubMed
    1. Zhang S, Li Y, Xin S, Yang L, Jiang M, Xin Y, et al. Insight into LncRNA- and CircRNA-mediated CeRNAs: regulatory network and implications in nasopharyngeal carcinoma-a narrative literature review. Cancers (Basel). 2022 doi: 10.3390/cancers14194564. - DOI - PMC - PubMed
    1. Zheng C, Chu M, Chen Q, Chen C, Wang ZW, Chen X. The role of lncRNA OIP5-AS1 in cancer development and progression. Apoptosis. 2022;27(5–6):311–321. doi: 10.1007/s10495-022-01722-3. - DOI - PubMed